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Both efficacy and clinical feasibility deserve consideration in translation of research outcomes. This study evaluated the feasibility of
rehabilitation programs within the context of a large randomized controlled trial of physical therapy. Ambulant participants with
Parkinson’s disease (PD) (n = 210) were randomized into three groups: (1) progressive strength training (PST); (2) movement
strategy training (MST); or (3) control (“life skills”). PST and MST included fall prevention education. Feasibility was evaluated in
terms of safety, retention, adherence, and compliance measures. Time to first fall during the intervention phase did not differ across
groups, and adverse effects were minimal. Retention was high; only eight participants withdrew during or after the intervention
phase. Strong adherence (attendance > 80%) did not differ between groups (P = .435). Compliance in the therapy groups was
high. All three programs proved feasible, suggesting they may be safely implemented for people with PD in community-based
clinical practice.
1. Introduction
Physical rehabilitation in Parkinson’s disease (PD) is a
growing field of investigation. Although a number of small
randomized controlled trials (RCT) have reported some
benefits of physical rehabilitation programs for people with
PD [1–5], the outcomes of recent systematic reviews remain
equivocal [6–8]. There are many excellent examples of
clinical trials, particularly those evaluating rehabilitation
outcomes (e.g., [2, 4, 9]). The existence of such rich
literature highlights the importance of ensuring high levels of
adherence and compliance with therapy protocols, as well as
carefully tracking attrition and adverse responses [10]. This
manuscript addresses that gap.
The conduct of clinical research presents challenges; trial
outcomes can be influenced by many variables related to
the rigor of research methods employed, such that even
carefully planned and well-funded clinical trials can fail
to yield high-quality data or allow results to be translated
into practice. In addition, exercise modalities aimed at
strengthening and preventing falls may present safety risks
to the potentially frail and debilitated participants enrolled
in physical rehabilitation clinical trials.
Participant retention has been identified as an issue in a
number of previous randomized controlled trials of physical
rehabilitation in PD, particularly those studies involving an
inactive control group [11, 12]. It has been suggested that
offering an alternative therapy as a control intervention may
improve retention in nonpharmacological randomized clin-
ical trials [11]. Without the option of blinding participants
to group allocation within a physical rehabilitation clinical
trial, the challenge becomes developing alternative therapy
programs that offer participants an equivalent participation
experience whilst minimizing overlap with the content of the
active intervention.
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Adherence and compliance are key variables influencing
the outcome of clinical trials in PD [13]. Within the context
of a physical rehabilitation trial, it is important to establish
not only when participants attend (adherence; [1, 13]),
but what activities they complete during their attendances,
that is, the extent of their engagement with the program
(compliance; [13]). Adherence and compliance, therefore,
reflect the adequacy and appropriateness of therapy content
for the sample and should be considered within the design
of a clinical trial by the development of appropriate therapy
and training protocols.
To date, few trials of physical rehabilitation programs
for PD have reported adherence and compliance data (e.g.,
[14]). Fewer studies have described in detail the strategies
used or recommended to maximize adherence and com-
pliance in this patient group. The purpose of this paper is
to report the safety, retention, adherence, and compliance
rates of a large RCT investigating the efficacy of physical
rehabilitation to reduce falls and improve mobility in people
with PD. In addition, strategies to improve adherence and
compliance will be described, and implications for future
research will be discussed.
2. Methods
2.1. Study Design. We conducted a single blind randomized
controlled trial to evaluate the effectiveness of two methods
of physical therapy combined with falls education to improve
mobility and decrease falls in people with PD, relative to a
control intervention [15]. Ethical approval was gained from
the relevant Ethics Committees, and all participants provided
written informed consent.
2.2. Participants. A convenience sample of 210 participants
with idiopathic PD was recruited between 2006 and 2009
throughout Melbourne, Australia from neurologists and
therapists working in clinics and rehabilitation centers,
from PD support groups and from community newspaper
advertisements. Eligible people were those who: (i) had a
confirmed diagnosis of idiopathic PD; (ii) were able to
walk (Hoehn and Yahr (HY) Stages 0-IV [16]); (iii) had
a Mini Mental State Examination (MMSE) score ≥24; (iv)
were willing and able to attend the therapy and assessment
program. Exclusion criteria were other medical conditions
that could limit or prevent exercising safely at the required
intensity, other prior neurological conditions affecting gait,
and dementia.
After screening and consent, participants were random-
ized to one of three groups: progressive strength training
(PST) combined with falls prevention education; movement
strategy training (MST) combined with falls prevention
education; or a control group (life skills; LS).
2.3. Intervention. The programs were delivered by clinical
staff employed in outpatient settings. All staff delivering the
intervention completed 2.5 hours training on the therapy
protocols, conducted by the study chief investigators. The
interventions were delivered in a once weekly two-hour
session for 8 weeks to groups of 3-4 participants. The
PST and MST interventions were delivered by a physical
therapist, and the LS program was delivered by occupational
therapists or social workers. An allied health assistant also
attended sessions as required to provide general assistance. In
addition, all participants were provided with a home exercise
program to be completed independently or with carer/family
assistance once a week.
The interventions are described in detail elsewhere [15,
17]. To summarize, the PST program comprised seven
strengthening exercises for core muscle groups of the lower
limbs and trunk, in accordance with the principles of PST
[18]. Exercises were progressed by adjusting the number of
sets and repetitions, by adding more weights to the vest, by
increasing the Thera-band (stretch elastic band) resistance
and by adjusting the step or chair height. Exercises were
individually tailored and progressed, taking into account
factors such as age, fitness level, comorbid health conditions
such as arthritis or back pain, and self-reported exercise
difficulty according to the Borg Perceived Exertion Scale [19].
The individualized home exercise programwas recorded on a
standardized home exercise sheet template each week by the
therapist. A booklet with photos of each exercise, a gym step,
vest with weights, and Thera-band were supplied for use at
home during the intervention phase.
The MST program comprised the individualized teach-
ing of training strategies to enhancemovement performance,
improve balance and mobility, and to prevent falls, according
to the principles outlined by Morris et al. [20–22]. Partic-
ipants practised using strategies such as attention, verbal,
and external cues while performing seven functional tasks
such as sit to stand, moving from chair to chair, standing
and reaching, or walking and turning, either in single or
dual task conditions. A booklet with photos and details of
each exercise was provided to each participant. Exercises
were individually tailored to the functional level of each
participant, and progression of each task varied according
to need and ability. A home exercise program tailored to the
individual’s level was prescribed each week by the therapist.
Both the PST and MST groups received 10–15 minutes of
structured falls education component at each weekly session,
incorporating an overview of risk factors and strategies to
prevent falls. This was based upon the content of the booklet:
Don’t fall for it. Falls can be prevented!—A Guide to Preventing
Falls for Older People booklet [23].
The control intervention comprised guided discussion
sessions on PD-related topics such as the impact of PD on
the individual and family, fatigue management, relaxation,
medication, communication, and community services. The
LS session did not include any content related to falls
education, exercise, walking, or balance. Therapists also
suggested activities such as reflection activities and relaxation
practice to be completed once a week at home.
2.4. Outcome Measures. All participants were tested by
trained blinded physical therapist assessors at baseline
(T1), one week after the 8-week intervention (T2), and
at 3 months (T3) and 12 months (T4) after intervention.
The primary outcome measure was falls over 12 months
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after-intervention, as detailed previously [15]. Secondary
outcome measures included measures of mobility, activity
limitations, and quality of life.
2.5. Outcome Measures for the Intervention Phase. Interven-
tion therapists recorded key details of therapy delivered after
each session using custom designed forms. The therapy
record for the intervention groups indicated compliance with
key therapy concepts. For the MST group, this reflected
the individual tailoring of activities to address functional
movement difficulties. For the PST group, the record detailed
the exercises, number of repetitions and sets, weights, and
Thera-band resistance level. All participants were screened
weekly at the intervention sessions for new adverse events,
including new muscle soreness related to therapy. Falls
were monitored using a Falls Calendar protocol [15]. This
required people to enter falls on a calendar as they occurred
and to telephone a falls hotline to answer questions relating
to fall circumstances and consequences. Falls Calendars were
completed during the intervention phase and for 12 months
following intervention.
For the purposes of this study, feasibility was adopted
as an umbrella term, encompassing the constructs of safety,
retention, adherence, and compliance. Safety during the
intervention phase was monitored by: (i) structured weekly
screening by the intervention therapists for any new soreness
lasting longer than 48 hours related to therapy; (ii) recording
of adverse events that occurred during therapy; and (iii) fall
rate during the intervention phase. Retention was defined in
several ways: (i) the proportion of participants who attended
the first post-intervention assessment; (ii) the proportion of
participants who returned post-intervention Falls Calendars
(reflecting the primary outcome measure of the overall trial);
(iii) the proportion of participants who completed all follow-
up assessments compared to the number who completed
baseline assessments (note that this measure is the opposite
of “dropouts”). Adherence considered the consistency of
participant attendance at the intervention/control sessions.
Compliance to the intervention was determined by the
progression of exercises within each of the two intervention
groups as evidenced by therapy records.
2.6. Data Analysis. Demographic data were gathered for each
group for variables such as age, sex, disease duration, past
history of falls, and comorbidities. Kaplan-Meier survival
analysis was used to examine time to first fall during the
intervention phase of the trial and compared between groups
using Mantel-Cox log rank test. Between-group comparisons
of adherence were assessed using an independent samples
one-way Kruskal-Wallis test. Data were analysed using IBM
SPSS version 19.0 (SPSS Corp, Chicago, Ill, USA) or STATA 8
(Stata Corp, College Station, Tex., USA) statistical software.
3. Results
3.1. Participants. Two hundred ten participants (140 men,
mean age (SD) of 67.9 (9.6), range 44–89 years) were
randomized. Participants generally had mild to moderately
severe PD, reflected by a median modified HY stage (IQR) of
2.5 (2-3) and mean (SD) disease duration of 6.7 (5.6) years.
Activity limitations, as measured by the Unified Parkinson’s
Disease Rating Scale (UPDRS) Part II activities of daily
living, were also mild (mean (SD); 11.6 (5.9)). One hundred
sixteen participants (55%) reported having falls over the
previous 12 months, of whom 74 (64%) were repeat fallers.
Freezing of gait was reported by more than half of the
participants. Arthritis was the most commonly reported
health condition, present in 92 (44%) of the sample, and
48 (23%) participants had a history of cancer or heart
disease. The majority of participants were taking levodopa
preparations or a combination of PD medications, with 19
on no PD-pharmacotherapy. One hundred fourteen (54%)
participants were prescribed four or more medications, with
89 (42%) taking psychotropic medication.
3.2. Delivery of Interventions. The interventions were under-
taken in four different outpatient centers located in different
regions of Melbourne. Across the three years of the RCT, 8
physical therapists delivered the MST, 10 physical therapists
delivered the PST and 6 occupational therapists or social
workers delivered the LS program. Therapist professional
experience varied markedly from new graduate (<1 year) to
highly experienced (>30 years).
3.3. Safety. The safety of the interventions was assessed in
three ways and is reported in Table 1. Structured weekly
screening during the intervention phase identified new
soreness lasting longer than 48 hours in 28 individuals (PST
n = 18; MST n = 10). Seven individuals reported more
than one episode of soreness (PST n = 6; MST n = 1).
Typical reports included a transient increase of preexisting
low back, hip or knee pain related to osteoarthritis, resolved
by a modified program or over-the-counter medication.
Fewer than one quarter of these participants attended a
health service practitioner because of new soreness. No new
soreness was reported to persist beyond the intervention
phase and require intervention.
Secondly, three incidents occurred during the actual
intervention sessions. Two MST participants reported single
episodes of dizziness with subsequent medical assessment
that were resolved without intervention or sequelae. A single
participant from the PST group fell during the therapy
session, with no reported injury. None of these incidents
resulted in any ongoing consequence.
The third safety evaluation examined falls in 203 partic-
ipants during the intervention phase. Fifty-eight people fell
during this phase: (PST n = 10, MST n = 24, LS n = 24).
Falls frequency varied markedly; 32 people fell once or twice;
19 fell between 3 to 9 times; 7 fell 10 or more times. The
median time to the first fall during the intervention phase
was 14 days in the PST group and 9 days in the MST and
LS groups. The time to first fall did not differ significantly
between groups; Log rank test (Mantel Cox), Chi square =
2.08, df = 2, P = 0.353.
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Table 1: Safety during the intervention phase.
PST MST LS
“New soreness > 48 hrs.”
Occasions of new soreness (n = 36) 25 11 0
Participants reporting new soreness (n = 28) 18 10 0
Incidents during therapy sessions 1 (fall; no sequelae) 2 (dizziness; no sequelae) 0
Falls during intervention phase
Number of fallers (n) 10 24 24
Falls frequency: median (IQR) 0 (0) 0 (0-1) 0 (0-1)
Falls frequency: range (n) 0–7 0–24 0–52
Median time to first fall (days) 14 9 9
Table 2: Assessments attended across the course of the trial.
Assessment PST n (% of randomized) MST n (% of randomized) LS n (% of randomized)
TI (Baseline assessment) 70 (100) 69 (100) 71 (100)
T2 (1 week after intervention phase) 69 (98.6) 68 (98.6) 59 (83.1)
T3 (3/months after intervention phase) 67 (95.7) 64 (92.8) 54 (76.1)
T4 (12 months after intervention phase) 65 (92.9) 63 (91.3) 56 (78.9)
3.4. Retention. Three aspects of retention of participants
were considered related to attendance at the three post-
therapy assessments and the return of Falls Calendars. The
study protocol had allowed for a drop-out rate of 15% when
determining the required sample size. Seven participants,
six in the LS group and one in the MST group, withdrew
prior to the intervention phase after being randomized to
a group. Reasons for withdrawal included poor health (LS
n = 2), a preference for the exercise group (LS n = 1),
unable or no longer wanting to attend (LS n = 2, MST
n = 1), and deceased (LS n = 1). Eight participants withdrew
from the study during or after the intervention phase and
did not return Falls Calendars during the 12 months follow-
up phase. Six of these withdrew from the LS program, two
due to health reasons, one as they did not want to continue
(unspecified reason), one because he felt the group was
“depressing”, and two as they were not exercising or receiving
falls education. One participant withdrew from PST for
health reasons, and one participant from the MST group
died of unrelated causes. One hundred ninety-six (93%) of
the participants completed the T2 assessment at the end of
the 8-week intervention phase (PST n = 69; MST n = 68;
LS/control n = 59; see Table 2).
Retention throughout the full trial period was high.
One hundred ninety-five participants (93%) returned one or
more Falls Calendars during the 12-month follow-up period
(PST n = 69, MST n = 67, LS n = 59). One hundred eighty-
four participants (88%) provided falls data for the entire 12
months (PST n = 65, MST n = 65, LS n = 54). In the
final evaluation of retention, 775 assessments of possible 840
(210 × 4 occasions) were completed (92%). Participation at
the final T4 assessment as a percentage of the total number
randomized showed 93% of people in the PST group were
reassessed, 91% of MST and 79% of participants in the LS
program.
3.5. Adherence. Eight participants were randomized, but did
not attend any therapy sessions (PST n = 0, MST n = 2, LS
n = 6). Adherence data are reported for the participants who
attended at least one intervention session (PST n = 70, MST
n = 67, LS n = 65). Ninety percent of the PST participants
attended between 6 and 8 sessions, with 3 participants (4%)
attending fewer than 5 sessions. Ninety-three percent of the
MST participants attended 6–8 sessions, with 2 participants
(3%) attending fewer than 5 sessions. Seventy-eight percent
of the LS participants attended between 6 and 8 sessions,
with six participants (9%) attending fewer than 5 sessions.
Participant attendance (as defined by attendance at ≥6
sessions or 75%) did not differ across the three groups
(independent samples Kruskal-Wallis, P = .435). The PST
group attended 82.5% of available sessions, the MST group
90.5%, and the LS group 80.7%.
3.6. Compliance
3.6.1. Progressive Strength Training Group. A review of the
therapy records indicated that 89% of the participants were
able to complete all seven suggested exercises within the 2-
hour session. The remaining 11% were able to complete six
exercises. Increasing the number of repetitions and/or sets
was the most common form of progression, with 97% of
participants (68 of 70) progressing in this manner. Eighty
percent (56 of 70) of the participants used the vest with
weights during the appropriate exercises. Of these, only 5
participants (9%) did not increase the weights across the
course of the intervention. Both the step platform and Thera-
band (to resist trunk extension/rotation) were used by all
participants. Thera-band resistance was increased for 57% of
participants.
3.6.2. Movement Strategy Training Group. A review of the
available therapy records (n = 64, missing data = 3)
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indicated that over 86% (55/64) of the participants were
able to routinely complete six or all seven activities within
the 2-hour period. Increasing the number of repetitions and
sets was the most common form of program progression,
in conjunction with increasing the difficulty of the task.
Progression of the task was highly variable according to each
individual’s task performance. For example, standing and
reaching to an object in front of the participant may have
progressed to moving the object further away, standing and
placing an object down on the ground or up on a high
shelf, to moving a heavier or more cumbersome object.
Similarly, walking a straight line with long steps might have
progressed to walking with a secondary motor task, with a
secondary cognitive activity, to an obstacle course; standing
up from a chair may have progressed by altering the height
or compliance of the chair, or to standing up with an object
in hand or standing up and walking off.
4. Discussion
The primary RCT described in this paper investigates
the ability of two types of physical therapy to prevent
falls in community-dwelling people with PD. The current
secondary examination of feasibility demonstrates that these
therapy programs can be successfully implemented within
the context of an RCT. It also suggests they are feasible and
may be safely translated to clinical practice.
4.1. Safety. As it was possible that these physical therapy
programs might present safety risks, the first aspect of
feasibility considered was the safety of the two active
interventions. Both physical therapy interventions carried
potential risks, either inherent in their content or specific
to the population being treated. Each intervention aimed
to extend participants to a high level of activity and
performance, as high intensity exercise has been shown to
be achievable in people with PD [24, 25]. The possibility,
thus, existed of some consequent muscle soreness and/or
joint stiffness, leading to the definition of a treatment-related
minor adverse event as “soreness that lasted more than
48 hours or required attendance at a health professional.”
Falls risk was potentially increased by aspects of the MST
program that targeted and challenged aspects of motor
performance such as balance, reach, and stride length. The
PST program explicitly encouraged participants to work with
increasing weights and resistance, potentially risking muscle,
and joint problems. Participants were primarily older people
(mean age 67.9 ± 9.7 years), potentially carrying a relatively
high proportion of orthopedic conditions (osteoarthritis,
osteoporosis) and other comorbidities [26]. Further, PD
itself is strongly associated with impaired balance and
increased falls risk [1, 27]. Finally, there was the possibility
that increased confidence, as a result of intervention, might
increase activity or risk taking and result in further falls.
Evaluation of the safety of these interventions was therefore
of key importance.
During the intervention, no adverse events with sequelae
were reported. There were no injuries during the therapy
sessions. Only 36 instances of “increased soreness > than
48 hours” occurred after the 1367 sessions attended, many
in individuals with a history of back pain or osteoarthritis.
A number of people were unsure whether it was the
intervention or concurrent activities such as gardening or
exercise that had triggered the soreness, and a visit to a health
professional was necessary in fewer than one quarter of the
instances reported. These results support the safety of the
PST and MST programs in an older population with mild-
moderate disability with a range of comorbidities.
There were no group differences between the time to
first fall during the intervention phase. This suggested
that neither working to improve participants’ functional
motor performance in the MST group nor increasing
their functional strength in the PST group may have led
them to undertake risky behaviors and fall as a result of
overconfidence. We conclude that both therapy programs
can be safely implemented in this population.
4.1.1. Retention. A key factor in achieving meaningful results
from an RCT is the retention of adequate participant num-
bers. Retaining participants from any older population in a
clinical trial over 12 months or more can be difficult [12, 13].
The retention level in the current trial exceeded expectations
in all three measures relating to post-intervention assessment
and Falls Calendar data. Falls data for the full twelve months
were available from 184 (88%) participants. This compares
very favorably with returns of 78% over 6 months in
people with PD [27] and over 75% return of monthly falls
questionnaires in elderly fallers [28].
The other measures of retention, attendance at T2 and
attendance at all 4 assessments over baseline attendance
(14 months from randomization), achieved greater than 90
percent retention, very similar to the 92% achieved over
6 months by Tickle-Degnan et al. [29]. Two other RCTs
in PD reported differing retention rates over 12-months as
measured by attendance at assessments. Only 51 percent of
people with PD in one 12 month randomized controlled
crossover trial attended all three of the assessments [12],
whereas results equivalent to ours were found in a much
smaller (n = 56) study of Qigong with almost 94 percent
of people returning for their 12 months assessment [30].
Differential attrition between intervention and control
groups can affect the equivalence of the groups achieved
by randomization at the outset of a trial [31, 32]. In most
cases, attrition tends to be greater in the control group
[12, 30], although sometimes the intervention carries a level
of adverse effects that may cause more people to drop out
of the active group [33, 34]. Whilst more participants were
lost to follow up in our control group than in the therapy
groups, the differences were small. The provision of a control
intervention that was similar in duration, group dynamics,
and relevance to the exercise interventions appeared to
optimize retention and may have limited dropouts.
4.1.2. Adherence. Adherence, as defined by session atten-
dance during the intervention phase, was also satisfactory
with over 80% of available sessions attended by each group.
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Two smaller RCTs in PD (n = 68 and 116 resp.) reported
adherences of 93% [2] and between 86% and 92% over
6 weeks intervention periods [2, 29]. Other reports of
adherence in the literature are either over much longer
periods [12, 14, 30], in different populations (e.g., [13, 28]),
or involved physical therapy in the home setting [1, 9].
The determinants of satisfactory adherence rates are likely
to be complex. There may be a degree of selection bias, as
people who are willing to participate in researchmay bemore
likely to adhere to a program than those who refuse. Other
factors such as locale, professional supervision by physical
therapists, and social interaction may be relevant [35].
4.1.3. Compliance. Evaluation of therapist and participant
compliance to the protocol interventions is important to
interpreting the key results of a trial. It also determines
how effectively the interventions can be implemented as
treatments in the wider context. Despite this, it is seldom
reported. In our study, over 85% of participants were able to
complete all or nearly all of the prescribed exercises, despite
a mean age of 68 years and mild to moderate signs of PD
(median modified HY of 2.5). Only one other paper, to
our knowledge, reports the ability of people with PD to
comply with the content of a therapy intervention to reduce
falls [14]. In this small RCT (n = 48), compliance with 6
months of exercise therapy performed primarily at home was
evaluated. Only 25% of participants were able to complete
all prescribed exercises, with another 25% completing fewer
than half of them, possibly because motivation may be
different when exercising alone.
We believe compliance with therapy content was
enhanced by the booklet of photographically illustrated
exercise descriptions provided to each participant in the
two exercise groups. Enlarged photographs were also placed
at exercise stations in the various therapy locations to
improve the accuracy of exercise performance, and correct
performance was further facilitated by the presence of both
a physical therapist and a trained assistant. The therapy
protocol clearly directed that each participant should be
working at a hard but achievable level (modified Perceived
Exertion Scale levels [19]) that should have fully engaged
participation.
The strong compliance with content may also reflect the
participants’ relationship with and confidence in the treating
therapists as well as the therapists’ confidence in the trial
exercise protocol. Importantly, the therapist was always the
final judge of how the participant was to perform each
activity and at what level, supporting their professional skill
and understanding. As this level of compliance with program
content was achieved by a number of different therapists of
widely varying years of clinical experience, it appears that the
content was well defined and easy to implement.
Although not formally assessed, many individuals from
our three groups volunteered that they had enjoyed their
participation. In part, this probably reflected the supportive
relationships and camaraderie that developed between group
members, reducing social isolation [36]. It was informally
observed that group members supported each other despite
differing levels of disability. Such information sharing has
been reported as a desired outcome in PD [36]. These factors
are likely to have enhanced adherence and compliance in the
therapy groups.
An important aspect to designing a randomized con-
trolled trial is setting up the control group. Ideally, a control
group should be exposed to similar duration and intensity
of contact time as the intervention group, meeting the needs
for education, attention, and socialization. The results of this
study suggest that the LS program fulfilled these aims. The
group’s focus on PD specific topics [36] such as medication
management, fatigue management, and communication was
a strong point, building on the camaraderie and mutual
support provided by members to each other. Control groups
can often suffer from poor retention and adherence [12],
particularly if they are simply a “wait list” group. Our
results and others [11, 37] suggest that participant-relevant
education helps improve group participation, particularly
if social interaction and support within the group can be
fostered.We conclude that guided small group discussions on
topics of relevance can be recommended as a viable control
program in the design of controlled clinical trials.
5. Conclusions
In the rehabilitation literature, there are few reports of
the feasibility, safety, and adverse events associated with
physical therapy for people living with Parkinson’s disease.
Our results address this gap and show that, when combined
with a falls education program, strategy training and strength
training can be safely implemented in a community-based
sample of people with idiopathic PD. We also found that
a life-skill social and education program was an effective
control intervention that maintained interest without pro-
viding the active ingredients of therapy. Protocols could be
easily followed by clinicians with varying levels of expertise,
allowing for replication in future trials throughout the world.
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